ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 400,19
-1,19%
Dow Jones
42 353,05
-0,41%
DAX
20 252,52
-0,48%
Brent Oil
76,935
-0,16%
Bitcoin
95 393,00
-1,54%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. AQSE

  6. Mydecine Innovations Group Inc (MYIG) Cours

Mydecine Innovations Group Inc

Mydecine Innovations Group Inc (MYIG)

AQSE
1,75
0,00
( 0,00% )
Mis à jour : -
Données en temps réel

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Statistiques et détails clés

Dernier
1,75
Prix Achat
0,00
Prix Vente
0,00
Volume échangé
0,00
0,00 Fourchette du Jour 0,00
1,00 Plage de 52 semaines 4,00
Clôture Veille
1,75
Ouverture
-
Dernière Transaction
Dernière heure de transaction
-
Volume moyen (3 m)
0,00
Volume financier
-
VWAP
-

MYIG Dernières nouvelles

Plus de nouvelles

Mydecine Innovations Group Inc - Mydecine Announces Filing of Q3 Financial Statements

Mydecine Innovations Group Inc - Mydecine Announces Filing of Q3 Financial Statements PR Newswire LONDON, United Kingdom, November 21 MYDECINE ANNOUNCES FILING OF Q3 FINANCIAL STATEMENTSVancouver...

21 Novembre 2024
UK Regulatory

Mydecine Innovations Group Inc - Suspension of Trading

Mydecine Innovations Group Inc - Suspension of Trading PR Newswire LONDON, United Kingdom, October 10 SUSPENSION OF TRADINGVancouver, British Columbia, 10 October 2024- Mydecine Innovations Group...

10 Octobre 2024
UK Regulatory

Mydecine Innovations Group Inc - MYDECINE ANNOUNCES FILING OF UNAUDITED INTERIM FINANCIAL STATEMENTS

Mydecine Innovations Group Inc - MYDECINE ANNOUNCES FILING OF UNAUDITED INTERIM FINANCIAL STATEMENTS PR Newswire LONDON, United Kingdom, August 22 MYDECINE ANNOUNCES FILING OF UNAUDITED INTERIM...

22 Août 2024
UK Regulatory

Mydecine Innovations Group Inc - Annual and Q1 Financial Statements

Mydecine Innovations Group Inc - Annual and Q1 Financial Statements PR Newswire LONDON, United Kingdom, July 08 MYDECINE ANNOUCES FILING OF AUDITED AND Q1 FINANCIAL STATEMENTSVancouver, British...

08 Juillet 2024
UK Regulatory

Mydecine Innovations Group Inc - Doc re: Bl-Weekly Status Report

Mydecine Innovations Group Inc - Doc re: Bl-Weekly Status Report PR Newswire LONDON, United Kingdom, June 14 MYDECINE PROVIDES Bl-WEEKLY STATUS REPORTVancouver, British Columbia, June 14, 2024...

14 Juin 2024
UK Regulatory

Mydecine Innovations Group Inc - Bl-Weekly Status Report

Mydecine Innovations Group Inc - Bl-Weekly Status Report PR Newswire LONDON, United Kingdom, June 03 MYDECINE PROVIDES Bl-WEEKLY STATUS REPORTVancouver, British Columbia, June 3, 2024- Mydecine...

03 Juin 2024
UK Regulatory

Mydecine Innovations Group Inc - Mydecine Provides Bl-Weekly Status Report

Mydecine Innovations Group Inc - Mydecine Provides Bl-Weekly Status Report PR Newswire LONDON, United Kingdom, May 17 MYDECINE PROVIDES Bl-WEEKLY STATUS REPORTVancouver, British Columbia, May 17...

17 Mai 2024
UK Regulatory

Mydecine Innovations Group Inc - Mydecine applies for management cease trade order

Mydecine Innovations Group Inc - Mydecine applies for management cease trade order PR Newswire LONDON, United Kingdom, May 03 MYDECINE APPLIES FOR MANAGEMENT CEASE TRADE ORDERVANCOUVER, British...

03 Mai 2024
UK Regulatory

Mydecine Innovations Group Inc - Management cease trade order

Mydecine Innovations Group Inc - Management cease trade order PR Newswire LONDON, United Kingdom, May 03 MYDECINE RECEIVES MANAGEMENT CEASE TRADE ORDERVANCOUVER, British Columbia, 3 May 2024...

03 Mai 2024
UK Regulatory

Mydecine Innovations Group Inc - Restructuring transactions and annual general and special meeting

Mydecine Innovations Group Inc - Restructuring transactions and annual general and special meeting PR Newswire LONDON, United Kingdom, May 03 MYDECINE INNOVATIONS GROUP INC.ANNOUNCES RESTRUCTURING...

03 Mai 2024
UK Regulatory
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1001.751.751.7500DE
4001.751.751.7500DE
12001.751.751.7500DE
26001.752.251.251691.75DE
52-0.75-302.54125381.75DE
156-8.25-82.51013.75166492.96388996DE
260-8.25-82.51013.75166492.96388996DE

MYIG - Frequently Asked Questions (FAQ)

What is the current Mydecine Innovations share price?
The current share price of Mydecine Innovations is 1,75p
What is the 1 year trading range for Mydecine Innovations share price?
Mydecine Innovations has traded in the range of 1,00p to 4,00p during the past year

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
JOG.GBJersey Oil and Gas Plc
 74,10
(20,49%)
15,8k
ALBA.GBAlba Min
 0,0284
(13,60%)
40,73M
INTIntelliAM AI plc
 79,00
(12,86%)
626
UNXUnigel Group plc
 112,50
(12,50%)
830
ECOB.GBECO Buildings Group Plc
 8,40
(12,00%)
11,9k
ARBNArbuthnot Banking Group PLC
 480,00
(-29,41%)
9
MTC.GBMothercare PLC
 3,6918
(-23,09%)
30k
TTAUTectonic Gold Plc
 0,12
(-20,00%)
153,05k
WTGWatchstone Group Plc
 2,40
(-20,00%)
9,25k
PRM.GBProteome Sciences plc
 3,01
(-14,00%)
179,84k
ALBA.GBAlba Min
 0,0284
(13,60%)
40,73M
ROCK.GBRockfire Resources Plc
 0,193
(10,29%)
23,51M
VRS.GBVersarien Plc
 0,0364
(-6,67%)
2,71M
ORCP.GBOracle Power Plc
 0,0219
(-12,40%)
1,31M
RKH.GBRockhopper Exploration
 28,268
(-13,69%)
1,12M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

AQSE
MYIG
Mydecine Innovations
LSE
0A8C
Airbnb
ASX
XTEN
Xtek
AMEX
ILF
iShares Latin America 40
BIT
P1LOX1
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés